Free Trial
OTCMKTS:BPMUF

Basilea Pharmaceutica (BPMUF) Stock Price, News & Analysis

Basilea Pharmaceutica logo
$54.00 0.00 (0.00%)
As of 03/27/2025

About Basilea Pharmaceutica Stock (OTCMKTS:BPMUF)

Key Stats

Today's Range
$54.00
$54.00
50-Day Range
$52.83
$54.00
52-Week Range
$38.60
$54.00
Volume
N/A
Average Volume
117 shs
Market Capitalization
$711.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union. It also offers medicine drug for invasive fungal infections. In addition, the company provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as offers treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. Further, it offers Fosmanogepix, an antifungal drug for the treatment of Candidemia which in Phase II clinical trials. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.

Remove Ads
Receive BPMUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Basilea Pharmaceutica and its competitors with MarketBeat's FREE daily newsletter.

BPMUF Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Kepler Capital Remains a Buy on Basilea Pharmaceutica (BSLN)
Basilea provides portfolio update and outlook
See More Headlines

BPMUF Stock Analysis - Frequently Asked Questions

Basilea Pharmaceutica's stock was trading at $52.83 at the start of the year. Since then, BPMUF stock has increased by 2.2% and is now trading at $54.00.
View the best growth stocks for 2025 here
.

The following companies are subsidiaries of Basilea Pharmaceutica: Conec UK Limited.

Shares of BPMUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/29/2025
Next Earnings (Estimated)
4/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BPMUF
CIK
N/A
Employees
147
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$175.50 million
Cash Flow
$1.16 per share
Price / Cash Flow
46.75
Book Value
($0.94) per share
Price / Book
-57.45

Miscellaneous

Free Float
N/A
Market Cap
$711.18 million
Optionable
Not Optionable
Beta
0.78

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:BPMUF) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners